As of July 14, 2026, Cytokinetics, Incorporated (CYTK) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Cytokinetics, Incorporated has a market capitalization of $10.42B, 124.43M shares outstanding, 453 institutional holders tracked. Key dilution vectors include 23.1K outstanding warrants, approximately 3 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
💰 Capital Raise
55%
• Critical: only 2.9 months cash remaining
🔁 Convertible Conversion
15%
• Convertible debt present: 7.0% potential dilution
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$10.42B
Shares Outstanding124.43M
Float123.86M
Cash$129.84M
Debt$292.02M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 9.9% shares (2026Q1 vs prior)
453 institutional holders · 177.68M shares
#1
T. Rowe Price Investment Management, Inc.
17.52M shares
#2
BlackRock, Inc.
16.55M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
10.98M shares
📉 Short Interest
Short Interest17.57M
Days to Cover5.3
% of Float14.2%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 07, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for CYTK Shareholders
Cytokinetics, Incorporated (CYTK) has a DilutionScore of 65/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.
Cash runway is a key watch item: CYTK has approximately 3 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for CYTK in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CYTK alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track CYTK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CYTK — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for CYTK
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.